Multidisciplinary program for promoting single prophylactic doses of cefazolin in obstetrical and gynecological surgical procedures.
A multidisciplinary cost-containment program for promoting the use of single prophylactic doses of cefazolin for obstetrical and gynecological surgical procedures is described. Following a one-month review of patient charts to identify the antimicrobial regimens used most frequently for prophylaxis in obstetrical and gynecological surgical procedures, the department of pharmacy services, with the cooperation of the pharmacy and therapeutics (P&T) committee and the departments of obstetrics and gynecology and infectious diseases, implemented an educational program to promote the use of single doses of cefazolin for surgical prophylaxis. The program included inservice education and distribution of letters of support and a therapeutics newsletter. Drug stocking patterns in the operating and delivery rooms were changed to make cefazolin more accessible, and the P&T committee formally restricted the use of prophylactic antimicrobial agents in obstetrical and gynecological surgical procedures to single doses of cefazolin unless a consulting infectious-disease physician recommended otherwise. Compliance with the program increased as each step was implemented; data collected 16 months after the program was initiated demonstrated a compliance rate of 78.8%. Based on comparison of data collected before initiation and six months after initiation of the program, an actual cost savings of +7,125 was realized, which extrapolates to +14,250 annually. No apparent adverse effects on patient care were noted. The multidisciplinary approach to promoting the use of single doses of cefazolin was effective.
Department of Pharmacy Services, Hartford Hospital, CT 06115.
K S
KS
Smith
R A
RA
Quercia
M S
MS
Chow
C H
CH
Nightingale
R
R
Quintiliani
J D
JD
Millerick
D002437:Cefazolin / Q000008:administration & dosage* / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery*; D006801:Humans; D007743:Labor, Obstetric; D010349:Patient Compliance; D010606:Pharmacy and Therapeutics Committee; D011247:Pregnancy; D011292:Premedication; D013530:Surgical Wound Infection / Q000517:prevention & control*
D002437:Cefazolin